Device Description
Identify make, model, software version, and key configuration details so implementers know precisely which technology and settings are approved for use.
A clear Assistive Technology Consent Form reduces ambiguity about device purpose, data sharing, and responsibilities. It documents informed consent, supports compliance with HIPAA and education privacy expectations, and provides evidence for accommodation plans, audits, and dispute resolution while protecting both the individual and the organization.
Typical users who complete, review, or approve these forms include clinicians, special education staff, assistive technology specialists, and the individual or guardian.
Keep copies in medical, educational, and personnel files so teams can coordinate care and demonstrate compliance across departments.
Student or patient signs when competent to consent, confirming device selection, usage conditions, and data-sharing permissions; signature authorizes implementation and routine adjustments consistent with documented goals and monitoring plans.
Parent, guardian, or legal representative signs for minors or those lacking capacity, providing legal authorization for device use, data access, and communications; include contact details and documentation of authority when required.
A public school implemented an assistive technology consent process for students with IEPs to standardize device approvals and training.
A rehabilitation clinic adopted a consent form for speech-generating devices used in therapy sessions.
Identify make, model, software version, and key configuration details so implementers know precisely which technology and settings are approved for use.
State functional goals tied to the device (for example, reading access, communication support) so progress can be measured and the AT plan justified.
Describe what data the device collects, how it is stored, who may access it, and retention periods to meet privacy obligations.
Specify who installs, configures, maintains, and trains on the device, plus contact details for follow-up and troubleshooting responsibilities.
Define trial periods, review dates, and conditions for renewal or adjustment to ensure the AT remains appropriate and effective.
Include signature blocks for the individual and authorized representative, with space for witness or notary lines if required by jurisdiction or policy.
Record date when consent first becomes effective.
Set periodic reviews, commonly every 6–12 months.
Specify trial length, e.g., 30–90 days.
Document process and required notice period for withdrawal.
Retention begins on creation or last effective date.
Choose a platform that supports required file formats, integrates with your systems, and meets authentication and compliance needs.
Confirm platform certifications and BAAs for healthcare, evaluate SSO for enterprise users, and verify audit-trail export for record retention.
| Field | Configuration |
|---|---|
| Authentication Method | Email link or SMS code with optional KBA |
| Signature Order | Sequential or parallel signer routing |
| Conditional Fields | Show fields based on role or responses |
| Notifications | Automated reminders and completion notices |
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial, no credit card | Varies by plan | Varies by plan | Varies by plan | Varies by plan |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | No cap | 100 envelopes/user/year | Varies | Varies | Varies |